Xconomy’s Digital Events →
* Required Field
Your Name: *
Your E-Mail: *
Your Remark:
Friend's Name: * Separate multiple entries with a comma. Maximum 5 entries.
Friend's E-Mail: * Separate multiple entries with a comma. Maximum 5 entries.
Image Verification: *
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy